Involvement of oxidative stress on the impairment of energy metabolism induced by Aβ peptides on PC12 cells: Protection by antioxidants

Neurobiology of Disease

Volumn 6, Issue 3, 1999, Pages 209-219

  Pereira, Cláudia ^a   Santos, Maria Sancha ^b   Oliveira, Catarina ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ANTIOXIDANT; GLUTATHIONE ETHYL ESTER; IDEBENONE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARTICLE; CELL VIABILITY; CYTOTOXICITY; ENERGY METABOLISM; GLYCOLYSIS; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RAT;

EID: 0033022771     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1999.0241     Document Type: Article

References (62)

1. Bass D. A., Parce J. W., Dechatelet L. R., Szejda P., Seeds M. C., Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation. J. Immunol. 130:1983;1910-1917.
2. Behl C., Davis J., Cole G. M., Schubert D. Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem. Biophys. Res. Commun. 186:1992;944-950.
3. Behl C., Davis J. B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
4. Behl C., Trapp T., Skutella T., Holsboer F. Protection against oxidative stress-induced neuronal cell death - A novel role for RU486. Eur. J. Neurosci. 9:1997;912-920.
5. Benzi G., Moretti A. Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Radical Biol. Med. 19:1995;77-101.
6. Blanc E. M., Keller J. N., Fernandez S., Mattson M. P. 4-Hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes. Glia. 22:1998;149-160.
7. Blanc E. M., Toborek M., Mark R. J., Hennig B., Mattson M. P. Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cell. J. Neurochem. 68:1997;1870-1881.
8. Bolaños J. P. V., Heales S. J. R., Peuchen S., Barker J. E., Land J. M., Clark J. B. Nitric oxide-mediated mitochondrial damage: A possible neuroprotective role for glutathione. Free Radical Biol. Med. 21:1996;995-1001.
9. Bowling A. C., Beal M. F. Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci. 56:1995;1151-1171.
10. Brautigan D. L., Ferguson-Miller S., Margoliash E. Mitochondrial cytochrome c: Preparation and activity of native and chemically modified cytochrome c. Methods Enzymol. 53:1978;128-164.
11. Bruce A. J., Malfroy B., Baudry M. β-Amyloid toxicity in organotypic cultures: Protection by EUK-8, a synthetic catalytic free radical scavenger. Proc. Natl. Acad. Sci. USA. 88:1996;3633-3636.
12. Butterfield D. A., Hensley K., Harris M., Mattson M. P., Carney J. β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: Implications to Alzheimer's disease. Biochem. Biophys. Res. Commun. 200:1994;710-715.
13. Cathcart R., Schwiers E., Ames B. N. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. Anal. Biochem. 134:1983;111-116.
14. Chen J. J., Yu B. P. Alterations in mitochondrial membrane fluidity by lipid peroxidation products. Free Radical Biol. Med. 17:1994;411-418.
15. Desagher S., Glowinski J., Prémont J. Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J. Neurosci. 17:1997;9060-9067.
16. Dyrks L. L., Dyrks E., Hartmann T., Masters C., Beyreuther K. E. Amyloidogenicity of βA4 and βA4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267:1992;18210-18217.
17. Esterbauer H., Schaur R. J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol. Med. 11:1991;81-128.
18. Goodman Y., Mattson M. P. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128:1994;1-12.
19. Goodman Y., Mattson M. P. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid β-peptide toxicity. J. Neurochem. 66:1996;869-872.
20. Greene L. A., Tischler A. S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA. 73:1976;2424-2428.
21. Greenamyre J. T., Young A. B. Excitatory amino acids and Alzheimer's disease. Neurobiol. Aging. 10:1989;593-602.
22. Hartley D. P., Ruth J. A., Petersen D. R. The hepatocellular metabolism of 4-hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase and glutathione S-transferase. Arch. Biochem. Biophys. 316:1995;197-205.
23. Hensley K., Carney J. M., Mattson M. P., Aksenova M., Harris M., Wu J. F., Foyd R., Butterfield D. A. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 91:1994;3270-3274.
24. Hoyer S. Abnormalities of glucose metabolism in Alzheimer's disease. Ann. N. Y. Acad. Sci. 40:1991;53-58.
25. Imberti R., Nieminen A.-L., Herman B., Lemasters J. J. Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: Protection by fructose, cyclosporin A and trifluoperazine. J. Pharmacol. Exp. Ther. 265:1993;392-400.
26. Jagust W. J., Seab J. P., Huesman R. H., Valk P. E., Mathis C. A., Reed B. R., Coxson P. G., Budinger T. F. Diminished glucose transport in Alzheimer's disease: Dynamic PET studies. J. Cereb. Blood Flow Metab. 11:1991;323-330.
27. Kalaria R. N., Harik S. I. Reduced glucose transporter at the blood brain barrier and in cerebral cortex in Alzheimer's disease. J. Neurochem. 53:1989;1083-1088.
28. Kang J., Lemaire H.-G., Unterbeck A., Salbaum J. M., Masters S. L., Grzesckik K.-H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature. 325:1987;733-736.
29. Keller J. N., Pang Z., Geddes J. W., Begley J. G., Germeyer A., Waeg G., Mattson M. P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: Role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69:1997a;273-284.
30. Keller J. N., Mark R. J., Bruce A. J., Blanc E., Rothstein J. D., Uchida K., Waeg K., Mattson M. P. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience. 80:1997b;685-696.
31. Kennedy A. M., Frackowiak R. S., Newman S. K., Bloomfield P. M., Seaward J., Roques P., Lewington G., Cunningham V. J., Rossor M. N. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familiar Alzheimer's disease. Neurosci. Lett. 186:1995;17-20.
32. Kruman I., Bruce-Keller A. J., Bredesen D., Waeg G., Mattson M. P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17:1997;5089-5100.
33. Lovell M. A., Ehmann W. D., Butler S. M., Markesbery W. R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 45:1995;1594-1601.
34. 2+ homeostasis and cell death. J. Neurosci. 15:1995;6239-6249.
35. Mark R. J., Blanc E. M., Mattson M. P. Amyloid β-peptide and oxidative injury in Alzheimer's disease. Mol. Neurobiol. 12:1996;211-224.
36. Mark R. J., Pang Z., Geddes J. W., Uchida K., Mattson M. P. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation. J. Neurosci. 17:1997;1046-1054.
37. Markesbery W. R., Lovell M. A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging. 19:1998;33-36.
38. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R. E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;379-389.
39. 2+ homeostasis in Alzheimer's disease. Trends Neurosci. 16:1993;409-414.
40. Mattson M. P., Barger S. W., Begley J. G., Mark R. J. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46:1995;187-216.
41. Miwa I., Adachi K., Murase S., Hamada Y., Sigiura M. 4-Hydroxy-2-nonenal hardly affects glycolysis. Free Radical Biol. Med. 23:1997;610-615.
42. Morelli A., Grasso M., Calissano P. Effect of nerve growth factor on glucose utilization and nucleotide content of pheochromocytoma cells (clone PC12). J. Neurochem. 47:1986;375-381.
43. Mosmann T. Rapid colorimetric assay for cellular growth and survival. J. Immunol. Methods. 65:1983;55-63.
44. Pappolla M. A., Sos M., Omar R. A., Bick R. J., Hickson-Bick D. L. M., Reiter R. J., Efthimiopoulos S., Robakis N. K. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J. Neurosci. 17:1997;1683-1690.
45. Pereira C., Santos M. S., Oliveira C. Mitochondrial function impairment induced by amyloid β-peptide on PC12 cells. NeuroReport. 9:1998;1749-1755.
46. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., Cotman C. W. Neurodegeneration induced by β-amyloid peptides in vitro: The role of protein assembly state. J. Neurosci. 13:1993;1676-1687.
47. Ragan C. I., Wilson M. T., Darley-Usmar V. M., Lowe P. N. Subfractionation of mitochondria, and isolation of the proteins of oxidative phosphorylation. Darley-Usmar V. M., Rickwood D., Wilson M. T. Mitochondria, a Practical Approach. 1987;79-112 IRL Press, London.
48. Schubert D., Behl C., Lesley R., Brack A., Dargusch R., Sagara Y., Kimura H. Amyloid peptides are toxic via a common oxidative mechanism. Proc. Natl. Acad. Sci. USA. 92:1995;1989-1993.
49. Sedmak J. J., Grossberg S. E. A rapid sensitive and versatile assay for protein using Coomassie blue G 250. Ann. Biochem. 79:1977;544-552.
50. Selkoe D. J. The molecular pathology of Alzheimer's disease. Neuron. 6:1993;487-498.
51. Shearman M. S., Hawtin S. R., Tailor V. J. The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by β-amyloid peptides. J. Neurochem. 65:1995;218-227.
52. Sims N. R. Altered glucose metabolism in Alzheimer's disease. Ann. Neurol. 27:1990;691-693.
53. Singh S. P., Gao Y., Kunapuli S. P., Ravindra R. Role of Gqα in insulin-stimulated glucose uptake by C6 glioma cells. NeuroReport. 8:1997;2359-2363.
54. Smith M. A., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A., Markesbery W. R. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 88:1991;10540-10543.
55. Smith M. A., Taneda S., Richey P. L., Miyata S., Yan S.-D., Stern D., Sayre L. M., Monnier V. M., Perry G. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA. 91:1994;5710-5714.
56. Smith M. A., Sayre L. M., Monnier V. M., Perry G. Radical ageing in Alzheimer's disease. Trends Neurosci. 18:1995;172-176.
57. Stocchi V., Cucchiarini L., Palma P., Crescentini G. Simultaneous extraction and reverse-phase high-performance liquid chromatography determination of adenine and pyridine nucleotides in human red blood cells. Anal. Biochem. 146:1985;118-124.
58. Subramaniam R., Roediger F., Jordan B., Mattson M. P., Keller J. N., Waeg G., Butterfield D. A. The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins. J. Neurochem. 69:1997;1161-1169.
59. Tisdale H. D. Preparation and properties of succinic-cytochrome c reductase (complex II and III). Methods Enzymol. 10:1967;213-215.
60. Yankner B. A., Duffy L. K., Kirschner D. A. Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides. Science. 250:1990;279-282.
61. Yankner B. A. Mechanisms of neuronal degeneration in Alzheimer's disease. Nature. 382:1996;685-691.
62. 2 generation. J. Neurochem. 67:1996;1595-1606.